Journal of Mass Spectrometry and Advances in the Clinical Lab
Published by Elsevier
ISSN : 2667-1468 eISSN : 2667-145X
Abbreviation : J. Mass Spectrom. Adv. Clin. Lab
Aims & Scope
The Journal of Mass Spectrometry and Advances in the Clinical Lab (JMSACL, formerly known as Clinical Mass Spectrometry) is an open access, pay-what-you-can journal and publishes peer-reviewed articles addressing mass spectrometry and other advances in Laboratory Medicine and Pathology with a focus on development of diagnostic and related applications, including data science, to improve patient outcomes and reduce healthcare costs.
Beyond communication of the application of technologies in the routine clinical diagnostic setting, by publishing critically validated analytical protocols, the journal also addresses the translation of experimental techniques and analytical research into patient care, and the use of these technologies in clinical research and routine patient management.
The scope of the journal is not restricted to any particular technology, but covers the entire range of technologies and advancements that are expected to impact the clinical lab.
The journal encourages submissions having a clear path to patient care, including basic and translational research, and animal studies.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 3.4 |
2024 | 3.10 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.712 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
h-index
Year | Value |
---|---|
2024 | 20 |
Journal Rank
Year | Value |
---|---|
2024 | 7929 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 347 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Chemistry, Health Professions and Immunology and Microbiology, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology, Chemistry, Health Professions and Immunology and Microbiology, ensuring accessibility and quality in research dissemination.
This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.
Explore journals without APCs for alternative publishing options.